Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10

Proceedings of the National Academy of Sciences of the United States of America
E KojroF Fahrenholz

Abstract

Biochemical, epidemiological, and genetic findings demonstrate a link between cholesterol levels, processing of the amyloid precursor protein (APP), and Alzheimer's disease. In the present report, we identify the alpha-secretase ADAM 10 (a disintegrin and metalloprotease) as a major target of the cholesterol effects on APP metabolism. Treatment of various peripheral and neural cell lines with either the cholesterol-extracting agent methyl-beta-cyclodextrin or the hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin resulted in a drastic increase of secreted alpha-secretase cleaved soluble APP. This strong stimulatory effect was in the range obtained with phorbol esters and was further increased in cells overexpressing ADAM 10. In cells overexpressing APP, the increase of alpha-secretase activity resulted in a decreased secretion of Abeta peptides. Several mechanisms were elucidated as being the basis of enhanced alpha-secretase activity: increased membrane fluidity and impaired internalization of APP were responsible for the effect observed with methyl-beta-cyclodextrin; treatment with lovastatin resulted in higher expression of the alpha-secretase ADAM 10. Our results demonstrate that cholesterol reduction promotes the no...Continue Reading

References

Feb 21, 1992·Cell·K G RothbergR G Anderson
Nov 27, 1991·Biochemical and Biophysical Research Communications·W ArakiJ Kimura
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M R PalmertS G Younkin
Dec 1, 1994·The Journal of Cell Biology·E J SmartR G Anderson
Feb 23, 1996·The Journal of Biological Chemistry·S Bodovitz, W L Klein
Nov 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K H Weisgraber, R W Mahley
Jun 5, 1997·Nature·K Simons, E Ikonen
Sep 9, 1997·Biochemistry·G GimplF Fahrenholz
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M SimonsK Simons
Jun 12, 1998·Nature Medicine·S J LeeK S Kosik
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MezianeA Ungerer
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·S LammichF Fahrenholz
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·A SubtilT E McGraw
Mar 9, 2000·Trends in Endocrinology and Metabolism : TEM·F F MoebiusH Glossmann
Sep 2, 2000·Current Opinion in Neurology·J F Dartigues, L Letenneur
Nov 23, 2000·Lancet·H JickD A Drachman
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER

❮ Previous
Next ❯

Citations

Oct 23, 2002·Journal of Neuroscience Research·Katsuhiko Yanagisawa
May 24, 2007·Molecular Neurobiology·Michael T Maloney, James R Bamburg
Feb 16, 2010·Aging Clinical and Experimental Research·Francesco PanzaAlberto Pilotto
Feb 2, 2008·Cellular and Molecular Life Sciences : CMLS·A J Beel, C R Sanders
Sep 22, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Cristina CecchiGianfranco Liguri
Mar 9, 2011·Psychopharmacology·Tessa N DoumaRonald S Oosting
Jun 7, 2005·Experimental Brain Research·Kina HöglundKaj Blennow
Oct 5, 2011·Experimental Brain Research·Kristina Endres, Falk Fahrenholz
Feb 21, 2006·European Journal of Clinical Pharmacology·G P ParaleN V Panchal
May 4, 2006·European Biophysics Journal : EBJ·Silvia DanteNorbert A Dencher
Jul 31, 2009·European Biophysics Journal : EBJ·Carlos J BaierFrancisco J Barrantes
Sep 29, 2009·Journal of Bioenergetics and Biomembranes·Anna ColellJosé C Fernández-Checa
Dec 10, 2003·Current Atherosclerosis Reports·Paolo Calabro, Edward T H Yeh
Jan 19, 2013·Current Atherosclerosis Reports·Christiane Reitz
May 4, 2010·Molecular Neurobiology·Xiaoguang YangJames C-M Lee
Jan 18, 2013·Neurotoxicity Research·Yue-E ShenLi-Ming Zhang
May 29, 2004·Neurobiology of Aging·Sophie B GaudreaultJudes Poirier
Dec 21, 2002·Pharmacology & Therapeutics·Yoshihisa Kitamura, Yasuyuki Nomura
Jul 18, 2002·Trends in Pharmacological Sciences·Diana Ines Dominguez, Bart De Strooper
Mar 8, 2002·Trends in Neurosciences·T Hartmann
Oct 24, 2002·Neurobiology of Aging·W Gibson WoodSvetlana V Chochina
Feb 26, 2003·Neurobiology of Aging·M Axel WollmerAndreas Papassotiropoulos
Jul 30, 2003·Neurobiology of Aging·Barbara BorroniAlessandro Padovani
Jan 25, 2003·Experimental Gerontology·Marco Racchi, Stefano Govoni
Dec 7, 2002·Trends in Biochemical Sciences·Gerald GimplFalk Fahrenholz
Dec 12, 2002·Micron : the International Research and Review Journal for Microscopy·J R Harris
Jun 26, 2003·The International Journal of Biochemistry & Cell Biology·Yan LingNoor Kalsheker
Oct 9, 2001·Drug Discovery Today·T E. Golde, C B. Eckman
Sep 1, 2001·Trends in Molecular Medicine·M Hiltunen, H Soininen
Aug 28, 2003·Lancet Neurology·Elio ScarpiniHoward Feldman
Nov 28, 2012·ACS Chemical Neuroscience·Alaa H Abuznait, Amal Kaddoumi
Jul 6, 2007·Nature Clinical Practice. Neurology·Haipeng ChengGopal Thinakaran
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Carl P Blobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
M SimonsKai Simons
Proceedings of the National Academy of Sciences of the United States of America
K FassbenderTobias Hartmann
© 2021 Meta ULC. All rights reserved